MYH14 and myocarditis: Our preliminary experiment confirmed that only pembrolizumab (human anti-PD-1 monoclonal antibody) intraperitoneally injected in the xenotransplanted tumor nude mice for 14 consecutive days could not induce ICI-related myocarditis, which was mainly caused by myosin immunization in our study.